Abiopharma

PREDICTIVE ONCOLOGY INC. (AGPU) Announces Executive and Board Changes PREDICTIVE ONCOLOGY INC. (AGPU) announced changes to its leadership team and board of directors. Directors or was appointed. The position includes: Compensation Committee, the Committee. The change is effective as of April 10, 2026. Executive Changes Details:

• Personnel Involved: Directors or, Certain Officers, Chief Financial
• Actions: Appointed, Departed
• Committee Assignments: Compensation Committee, the Committee
• Effective Date: April 10, 2026
  • expected income trajectory, business model performance, and market opportunity. These statements involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including competition, GPU supply availability, customer concentration, deployment timelines, performance obligations, macroeconomic conditions, and other risks described in the Company's filings with the U.S. Securities and Exchange Commission. Contract figures represent total signed contract value; executed agreements may be subject to conditions, deployment timelines, and performance obligations, and income recognition may differ from total contract value. Axe Compute undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this release. Contract figures represent total signed contract value. Executed agreements may be subject to conditions, deployment timelines, and performance obligations. Revenue recognition may differ from total contract value and estimated income. Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 10.1* Employment Agreement, dated as of April 16, 2026